Bioniche announces issuance of fresh patents for MCC.

Bioniche announces issuance of fresh patents for MCC, Oligonucleotide technology platforms – Japanese patent issuances facilitate commercialization of MCC in Japan – Bioniche Existence Sciences Inc. , a research-based, technology-powered Canadian biopharmaceutical organization, today announced the issuance of several patents because of its proprietary Mycobacterial Cell Wall-DNA Complex composition and its own Oligonucleotide technology system viagra bivirkninger . The following is a listing of the Bioniche MCC patent applications which have been allowed or released in the many worldwide jurisdictions: 1.